A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities.
Phase of Trial: Phase IV
Latest Information Update: 07 Mar 2011
At a glance
- Drugs Imiquimod (Primary) ; Methyl aminolevulinate (Primary)
- Indications Basal cell cancer; Bowen's disease
- Focus Therapeutic Use
- 07 Mar 2011 New trial record